Stem cell treatment for spinocerebellar ataxia
Treatments studied
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study tests a single injection of umbilical cord stem cells for adults with spinocerebellar ataxia, a condition that affects balance and coordination. The goal is to see if it can slow down or improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with spinocerebellar ataxia (a condition affecting balance and coordination).
- Your ataxia severity score is between 2 and 5, which means mild to moderate symptoms.
- You are able to walk 8 meters (about 26 feet) for a walking test.
- You have not received any stem cell treatment in the past 6 months.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You do not have severe heart, kidney, liver, or blood conditions, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new kind of deep brain stimulation that adjusts automatically to improve balance and coordination in adults with SCA6, a genetic form of ataxia. It may help patients who can still walk but have moderate to severe symptoms.
This study tests if deep brain stimulation (putting a device in the brain to send mild electrical pulses) can improve balance and movement in people with spinocerebellar ataxia type 6 (SCA6), a genetic condition that causes trouble walking and coordination.
This trial tests a non-invasive brain stimulation method to see if it can improve movement and balance in people with spinocerebellar ataxia type 3. It aims to find the best settings for this treatment.
This study follows people with certain types of spinocerebellar ataxia (a group of conditions that cause progressive movement problems) to understand how the disease changes over time and how genes might influence it. It may help researchers learn more about these conditions and support future treatments.
This trial tests an experimental stem cell treatment for people with SCA3, a genetic condition that affects balance and coordination. The goal is to see if the treatment can help improve or slow down these symptoms.
This study tests a new treatment using special cells (stem cells) and their tiny particles (exosomes) to see if they are safe and help improve symptoms. It is for people with spinocerebellar ataxia, a condition that affects movement and coordination.
Hear when a new Spinocerebellar Ataxia Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.